Bolezni sovremennykh tekhnologiy, ili intsidentalomy gipofiza (po materialam klinicheskikh rekomendatsiy Endocrine Society)
- Авторлар: Volkova N.I1, Antonenko M.I1
-
Мекемелер:
- Шығарылым: № 16 (2012)
- Беттер: 92-97
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279940
- ID: 279940
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
The development of imaging technologies increased the frequency of detection of tumors (incidentalomas), which originally were not the cause for the search, and were detected sporadically during imaging performed for a reason, not initially associated with dysfunction of the organ or suspected its dysfunction. The article describes the main problems of diagnosis of pituitary tumors, and highlights the latest clinical recommendations on the management of this condition.
Толық мәтін
Әдебиет тізімі
- Nammour G.M., Ybarra J., Naheedy M.H., et al. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997; 314:287-91.
- Feldkamp J., et al. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf.) 1999;51:109-13.
- Oyama K., Sanno N., Tahara S., Teramoto A. Management of pituitary incidentalomas: according to a survey of pituitary inciden-talomas in Japan. Semin Ultrasound CT MR 2005;26:47-50.
- Freda P.U., et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96(4):894-904.
- Aron D.C., Howlett T.A. Pituitary incidentalomas. Endocrinol Metab Clin North Am 2000; 29:205-21.
- Johnson M., Hoare R.D., Cox T., et al. The evaluation of patients with a suspected pituitary microadenoma: computer tomography approximately magnetic resonance imaging. Clin Endocrinol (Oxford) 1992;36:335-38.
- Kulkarni M., Lee K., McArdle C., et al. MR imaging of pituitary microadenomas: technical considerations and CT correlation. Am J Neuroradiol 1988;9:5-11.
- Connor S., Penney C. MRI in the differential diagnosis of a sellar mass. Clin Radiol 2003; 58:20-31.
- Chidiac R.M., Aron D.C. Incidentalomas: a disease of modern technology. Endocrinol Metab Clin N Am 1997;26:233-53.
- Gao R., Isoda H., Tanaka T., et al. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images. Eur J Radiol 2001; 39:139-46.
- Tabarin A., Perez P. Pros and cons of screening for occult Cushing syndrome. Nat Rev Endocrinol 2011;22,7(8):445-55.
- Tietz's Applied Laboratory Medicine, 2nd ed. Scott MG, Gronowski AM, Eby CS, eds. Hoboken NJ: Wiley-Interscience, a John Wiley & Sons, Inc. Publication, 2007;679.
- Molitch M.E. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 2008;37:151-71.
- Nieman L.K., et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526-40.
- Karavitaki N., Ansorge O., Wass J.A. Silent corticotroph adenomas. Arq Bras Endocrinol Metabol 2007;51:1314-18.
- Gruber A., Clayton J., Kumar S., et al. Pituitary apoplexy: retrospective review of 30 patients -is surgical intervention always necessary? Br J Neurosurg 2006;20:379-85.
- Arafah B.M., Kailani S.H., Nekl K.E., Gold, R.S., Selman W.R. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab. 79, 348-354 (1994).
- Arafah B.M. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62:1173-79.
- Greenman Y., Tordjman K., Osher E., et al. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol (Oxf) 2005;63:39-44.
- Lohmann T., Trantakis C., Biesold M., et al. Minor tumour shrinkage in nonfunctioning pituitary adenomas by longterm treatment with the dopamine agonist cabergoline. Pituitary 2001;4:173-78.
- Pivonello R., Matrone C., Filippella M., et al. Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 2004;89:1674-83.
- Shomali M.E., Katznelson L. Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas. Pituitary. 5, 89-98 (2002).
- Merola B., Colao A., Ferone D., et al. Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. Horm Res 1993;40:149-55.
- de Bruin T.W., Kwekkeboom D.J., Van't Verlaat, et al. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-17.
- Colao A., DiSomma C., Pivonello R., et al. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 1992; 15:905-15.
Қосымша файлдар
